Warren Buffett's Successor, Greg Abel, Cashed Out on UnitedHealth. But Is the Stock a Steal at Its Current Valuation?

Greg Abel, Berkshire Hathaway's new CEO, sold the company's entire 5 million+ share position in UnitedHealth Group earlier this year, reversing Warren Buffett's purchase from the previous year. Despite the sale, UnitedHealth has made significant recovery progress through cost management, pricing adjustments, and AI investments. At 23x forward earnings, the stock is reasonably priced and considered a solid long-term healthcare holding, though not an absolute steal.

07/13/2026, 5:05 AM • The Motley Fool

History Says Doing This 1 Thing Will Score You an Investing Win -- Even After a Market Crash.

Despite recent market gains driven by AI stocks, valuations are at historically expensive levels similar to the dot-com bubble. The article recommends a simple strategy: invest in quality stocks and hold them long-term. History shows the S&P 500 has always recovered after crashes, making buy-and-hold the key to investing success.

07/11/2026, 4:02 AM • The Motley Fool

Don't Buy UnitedHealth Group (UNH) Stock Before Reading This

While UnitedHealth Group operates in the growing healthcare industry and has strong long-term performance, the article advises caution due to slow recent growth (2% revenue growth), ongoing DOJ investigations into Medicare billing practices, claims denial lawsuits, and challenges in its Medicare Advantage program forcing membership reductions. Despite AI investments and attractive valuation metrics, these headwinds make it a less compelling investment opportunity.

07/08/2026, 5:05 PM • The Motley Fool

This Stock Stumbled Last Year. Now It's the First Half's Best Performing Mega-Cap Healthcare Stock. Is It Too Late to Buy?

UnitedHealth Group rebounded strongly in the first half of 2026, gaining 25% after a difficult 2025 marked by earnings misses and leadership changes. The company has implemented recovery measures including cost management improvements, AI efficiency tools, and reduced prior authorization requirements. With a medical care ratio improving to 83.9% and strong revenue growth, analysts suggest it's not too late to invest despite the recent gains, as the company is still in early recovery stages.

07/07/2026, 6:10 PM • The Motley Fool

3 Stocks to Buy and Hold: The Long-Term Play for Your Portfolio

The article recommends three healthcare stocks for long-term buy-and-hold portfolios: Johnson & Johnson, Abbott Laboratories, and UnitedHealth Group. All three are praised for their stable dividends, strong cash flows, economic moats, and ability to weather economic downturns. Johnson & Johnson and Abbott are Dividend Kings with 64 and 54 consecutive years of dividend increases respectively, while UnitedHealth Group benefits from its dual-engine model combining insurance and healthcare delivery.

07/06/2026, 8:30 AM • The Motley Fool

3 Dividend ETF Picks That Could Build Serious Long-Term Wealth

The article examines three dividend-focused ETFs as wealth-building alternatives to growth stocks. SCHD offers higher yields through value-oriented dividend stocks, VIG combines growth potential with rising dividends, and DGRO provides a balanced hybrid approach. All three can build serious long-term wealth through dividend reinvestment if held patiently.

07/05/2026, 5:20 PM • The Motley Fool

Want Decades of Passive Income? Buy This ETF and Hold It Forever.

The Schwab U.S. Dividend Equity ETF (SCHD) is recommended as a long-term holding for passive income, offering a 3.25% dividend yield—more than three times the S&P 500's 1.07%. The ETF tracks 100 dividend-paying companies with at least 10 years of consecutive dividend payments and has seen its payout rise 211% over the past decade. Year-to-date performance shows 18.9% total return versus the S&P 500's 8.1%.

07/03/2026, 7:27 AM • The Motley Fool

1 Magnificent ETF I'm Buying Hand Over Fist in 2026

Matt DiLallo highlights the Schwab U.S. Dividend Equity ETF (SCHD) as his top ETF pick for 2026, praising its focus on 100 high-quality dividend growth stocks. The ETF has delivered 13.3% annualized returns since 2011 and offers a 3.4% yield, significantly above the S&P 500's 1.1%. DiLallo notes the ETF complements his existing dividend portfolio by providing exposure to quality dividend stocks he doesn't currently own, such as UnitedHealth Group.

07/02/2026, 9:30 AM • The Motley Fool

3 Recession-Proof Dividend Stocks You Can't Go Wrong With in July

With recession concerns persisting for 2026-2027, the article recommends three recession-resistant dividend stocks: Kroger (strong grocery market position with growing e-commerce), UnitedHealth Group (essential healthcare services with improved earnings and government rate approval), and Waste Management (essential waste services with steady revenue growth). All three offer reliable dividends and should perform well during economic downturns.

06/30/2026, 3:25 AM • The Motley Fool

UnitedHealth Stock Has Quietly Soared 80% off Its Low. Is the Worst Finally Behind It?

UnitedHealth stock has rebounded 80% from its 2025 low of $234.60 to near $427, outpacing the S&P 500. The company's medical care ratio improved and management raised 2026 earnings guidance, signaling operational stabilization. However, the stock's forward P/E ratio has risen to 23 from 13, and an unresolved Department of Justice investigation into Medicare Advantage billing practices creates uncertainty. The analyst suggests the easy gains have been made and recommends watching from the sidelines.

06/27/2026, 6:03 AM • The Motley Fool

UnitedHealth is Near its 52-Week High. Wall Street Is Starting to Notice This Blue Chip Stock -- and So Should You.

UnitedHealth Group (UNH) has surged 25% this year and is trading near its 52-week high. The healthcare giant offers revenue growth, a solid 2.3% dividend yield with 17 consecutive years of increases, and resilience against economic downturns. The company is deploying a $1.5 billion AI initiative to reduce administrative costs and improve margins, while managing rising medical costs through responsive pricing strategies. Despite valuation concerns and industry-wide medical cost pressures, UnitedHealth's diversified business model and strong cash flow position it as an attractive investment for income and total-return focused investors.

06/26/2026, 3:30 PM • The Motley Fool

Is UnitedHealth Stock an Undervalued Healthcare Stock to Buy?

UnitedHealth Group stock has been rising in recent months, but investors should remain cautious. The article suggests that investors are appreciating management's response to higher customer-service costs, though the stock's recent gains warrant careful consideration before investing.

06/25/2026, 6:22 PM • The Motley Fool

Modern Therapy Group launches virtual intensive outpatient program for mental health

Modern Therapy Group has launched a virtual intensive outpatient program (IOP) for adults with depression, anxiety, trauma, and other mental health conditions. The program offers five days a week of clinician-led telehealth treatment, providing a middle ground between weekly therapy and inpatient care. Available in seven states with in-network coverage from major insurers including Blue Cross Blue Shield, Aetna, Cigna, and Optum/United.

06/24/2026, 6:54 PM • GlobeNewswire

2 Top-Tier Dividend ETFs that Complement Each Other Well to Invest in Right Now

The Schwab U.S. Dividend Equity ETF (SCHD) and Vanguard Dividend Appreciation ETF (VIG) are complementary dividend ETFs that together offer both high income and growth potential. SCHD focuses on high-quality dividend-paying companies and offers higher yields, while VIG emphasizes dividend growth and has greater exposure to tech stocks like Apple and Microsoft, providing better stock price appreciation.

06/21/2026, 10:30 AM • The Motley Fool

Healthcare Services Market Size to Worth USD 20.10 Trillion by 2035, Amid Rising Digital Healthcare Adoption – SNS Insider

The global healthcare services market is projected to grow from USD 8.62 trillion in 2025 to USD 20.10 trillion by 2035, with a CAGR of 8.87%. Growth is driven by rising chronic disease prevalence, aging populations, and digital healthcare adoption including telehealth and AI-enabled care. The U.S. market is expected to reach USD 4.93 trillion and Europe USD 6.25 trillion by 2035. Hospital services will dominate with 44% market share, while telehealth services will experience the fastest growth.

06/20/2026, 4:27 AM • GlobeNewswire